Pulmonary Rehabilitation in Advanced Lung Cancer Survivors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is for people who have previously been diagnosed with advanced stage non-small cell lung cancer (NSCLC). Many people with advanced stage NSCLC have trouble breathing and feel tired. People may be eligible for this study if they have advanced stage NSCLC and feel short of breath some of the time. NSCLC survivors may also experience things like fatigue and a lower quality of life. Pulmonary rehabilitation is a type of supportive treatment that may improve these symptoms. This study has two parts. The first part is a randomized trial where half of the participants receive eight weeks of pulmonary rehabilitation. The other half of participants do not do pulmonary rehabilitation and instead receive the treatment that their doctors would normally recommend. The purpose of this part of the research study is to understand if pulmonary rehabilitation can help people with advanced stage NSCLC have better functioning and less shortness of breath. The other part of the research study is an interview study. The purpose of doing interviews is to understand any challenges or obstacles that people with advanced stage NSCLC may have regarding pulmonary rehabilitation, as well as oncology care providers have with their participants going to pulmonary rehabilitation.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony rozpoznaniem zaawansowany rak płuca (stadium III lub IV)
- •Wiek 18 lat lub więcej
- •Stabilny stan zdrowia - bez pogorszenia w ostatnich 3 miesiącach
- •Problemy z oddychaniem (co najmniej umiarkowane)
- •Umiejętność porozumiewania się w języku angielskim
✗ Disqualifies
- •Leczenie chemioterapią i radioterapią jednocześnie
- •Postęp choroby w ostatnim czasie
- •Poważne problemy z sercem (niewydolność serca, zaburzenia rytmu)
- •Zawał serca lub niestabilna choroba wieńcowa w ostatnich 6 miesiącach
- •Udar mózgu lub zakrzepica w ostatnich 3 miesiącach
- •Zaburzenia umysłowe uniemożliwiające udział w badaniu
- •Wysokie ryzyko złamania kości lub uszkodzenia kręgosłupa
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 22, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Cleveland, United States
Trial contact
Melinda Hsu, MD, MS
Peronne Joseph
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/23/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.